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Background
Definitions of antipsychotics, hyperprolactinemia in
treatment with antipsychotics, side effects, risks and strat-
egies for management. Aim of the study: Independent,
open, naturalistic study. We assess prolactin levels of
patients treated with different atypical antipsychotics, the
correlation with the clinical symptoms of hyperprol-
actinemia /galactorea, gynecomastia and amenorrhea/, as
well as the control on symptoms, complaints and quality
of life in these patients.
Materials and methods
We evaluate the prolactin levels of 30 patients with diag-
nosis “paranoid schizophrenia” who are treated with risp-
eridone, amisulpiride and other antipsychotics in variable
dosages. A battery of tests /CGI-S, BPRS/ is used. The
observation is conducted within the period of 6 months.
The prolactin level is analyzed twice, irrespectively of the
presence or the lack of clinical manifestations. The
patients are analyzed in one and the same laboratory. The
symptoms of clinically manifested hyperprolactinemia
are actively demanded by the healing psychiatrist, as all
patients, regardless of the presence or the lack of clinical
manifestations of hyperprolactinemia, are consulted
endocrinologist and a physical examination is held. An
instrument for assessment of the involved patients is cre-
ated.
Results
Patients without clinical symptoms of hyperprolactine-
mia, have considerably increased levels of serum prolac-
tin. The average values for rispolept group are 120ng/ml
and 100ng/ml for solian group. A considerable reduction
of prolactin level when switching to another antipsychotic
is observed. In spite of the clinically significant high levels
of serum prolactin, some of the patients wouldn't like to
change the medicine.
Conclusions
Despite the target questions looking for hyperprolactine-
mia symptoms, the patients seldom share about them /
often, patients with clinically manifested hyperprolactine-
mia, are diagnosed after physical examination by endo-
crinologist.
A questionnaire for hyperprolactinemia symptoms is nec-
essary to be developed.
The data collected up to the moment, give us ground to
raise the question whether the group of so-called “atypical
neuroleptics” does not contain a subgroup of “typical”
atypics.
Our clinical observation shows a link between extrapy-
ramidal syndromes and hyperprolactinemia, although it
has not been instrumentally verified.
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